Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 August 1996 | Volume 125 Issue 4 | Pages 304-310
Objective: To review the literature on the cardiac effects of diabetes mellitus and hypertension.
Data Sources: A MEDLINE search of English-language articles published between 1980 and January 1996 was done using the terms diabetes mellitus, hypertension or blood pressure, and heart. References cited in identified articles were also reviewed.
Study Selection: Selected studies were divided into those addressing coronary artery disease or myocardial ischemia and those addressing nonischemic cardiomyopathy and its sequelae. Preference was given to articles about the cardiac complications of both diabetes mellitus and hypertension.
Results: Patients with diabetes and hypertension have a higher incidence of coronary artery disease than do patients with diabetes or hypertension alone. The former patients also show impaired systolic and diastolic function and have more severe left ventricular hypertrophy as documented by echocardiography and at autopsy. The structural myocardial damage seen in these patients has been attributed primarily to hypertension; the myocellular dysfunction has been attributed primarily to diabetes. In diabetic hypertensive patients with cardiomyopathy, coronary artery disease as well as structural and functional cardiac abnormalities are more pronounced than would be expected from either diabetes or hypertension alone.
Conclusions: Considerable evidence from both experimental animal models and humans points to hypertension as a critically important factor in the pathogenesis of severe heart disease in persons with diabetes. The pathogenetic sequelae of diabetes and hypertension are devastating to the heart and often lead to premature congestive heart failure, sudden cardiac death, and acute myocardial infarction. Strict control of arterial pressure and glycemia may prevent or even ameliorate heart disease in patients with hypertension and diabetes.
Author and Article Information
From The Chaim Sheba Medical Center, Tel-Hashomer, Israel; and the Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana.
REVIEW
Diabetic and Hypertensive Heart Disease
![]()
Current Author Addresses: Dr. Grossman: Hypertension Unit, The Chaim Sheba Medical Center, Tel-Hashomer, 52621 Israel.
This article has been cited by other articles:
![]() |
I. Z. Ben-Dov, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn Increased Prevalence of Masked Blood Pressure Elevations in Treated Diabetic Subjects Arch Intern Med, October 22, 2007; 167(19): 2139 - 2142. [Full Text] [PDF] |
||||
![]() |
H.-C. Lai, T.-J. Liu, C.-T. Ting, J.-Y. Yang, L. Huang, D. Wallace, P. Kaiser, and P. H. Wang Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60 Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E292 - E297. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Negro and H. Hassan The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 243 - 246. [Abstract] [PDF] |
||||
![]() |
P. T. Vlagopoulos, H. Tighiouart, D. E. Weiner, J. Griffith, D. Pettitt, D. N. Salem, A. S. Levey, and M. J. Sarnak Anemia as a Risk Factor for Cardiovascular Disease and All-Cause Mortality in Diabetes: The Impact of Chronic Kidney Disease J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3403 - 3410. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Chen, Y.-X. Shan, T.-L. Yang, H.-D. Lin, J.-W. Chen, S.-J. Lin, and P. H. Wang Insulin Deficiency Downregulated Heat Shock Protein 60 and IGF-1 Receptor Signaling in Diabetic Myocardium Diabetes, January 1, 2005; 54(1): 175 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Karvounis, C. E. Papadopoulos, T. A. Zaglavara, I. G. Nouskas, K. D. Gemitzis, G. E. Parharidis, and G. E. Louridas Evidence of Left Ventricular Dysfunction in Asymptomatic Elderly Patients with Non-insulin-dependent Diabetes Mellitus Angiology, September 1, 2004; 55(5): 549 - 555. [Abstract] [PDF] |
||||
![]() |
Z. Y. Fang, J. B. Prins, and T. H. Marwick Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications Endocr. Rev., August 1, 2004; 25(4): 543 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Tracqui, A Miras, A Tabib, J S Raul, B Ludes, and D Malicier Fatal overdosage with sildenafil citrate (Viagra1): first report and review of the literature Human and Experimental Toxicology, November 1, 2002; 21(11): 623 - 629. [Abstract] [PDF] |
||||
![]() |
R. C. Sampaio, J. E. Tanus-Santos, S. E. S. F. C. Melo, S. Hyslop, K. G. Franchini, I. M. Luca, and H. Moreno Jr Hypertension Plus Diabetes Mimics the Cardiomyopathy Induced by Nitric Oxide Inhibition in Rats Chest, October 1, 2002; 122(4): 1412 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eriksson, J. Lindstrom, and J. Tuomilehto Potential for the prevention of type 2 diabetes Br. Med. Bull., November 1, 2001; 60(1): 183 - 199. [Full Text] [PDF] |
||||
![]() |
G. C. Fonarow Quality Indicators for the Management of Heart Failure in Vulnerable Elders Ann Intern Med, October 16, 2001; 135(8_Part_2): 694 - 702. [Full Text] [PDF] |
||||
![]() |
A Mosterd, B Cost, A.W Hoes, M.C de Bruijne, J.W Deckers, A Hofman, and D.E Grobbee The prognosis of heart failure in the general population. The Rotterdam Study Eur. Heart J., August 1, 2001; 22(15): 1318 - 1327. [Abstract] [PDF] |
||||
![]() |
E. Grossman, F. H. Messerli, and U. Goldbourt High Blood Pressure and Diabetes Mellitus: Are All Antihypertensive Drugs Created Equal? Arch Intern Med, September 11, 2000; 160(16): 2447 - 2452. [Abstract] [Full Text] |
||||
![]() |
P. C. Deedwania Hypertension and Diabetes: New Therapeutic Options Arch Intern Med, June 12, 2000; 160(11): 1585 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Abizaid, G. S. Mintz, A. Abizaid, R. Mehran, A. J. Lansky, A. D. Pichard, L. F. Satler, H. Wu, K. M. Kent, and M. B. Leon One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms J. Am. Coll. Cardiol., September 1, 1999; 34(3): 707 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Abizaid, G. S. Mintz, R. Mehran, A. Abizaid, A. J. Lansky, A. D. Pichard, L. F. Satler, H. Wu, C. Pappas, K. M. Kent, et al. Long-Term Follow-Up After Percutaneous Transluminal Coronary Angioplasty Was Not Performed Based on Intravascular Ultrasound Findings : Importance of Lumen Dimensions Circulation, July 20, 1999; 100(3): 256 - 261. [Abstract] [Full Text] [PDF] |
||||